Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Days Inventory for the
three
months ended in Mar. 2026 was 119.32.
Inventory Turnover measures how fast the company turns over its inventory within a year.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.76.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.87.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS Total Inventories Related Terms
MEDITERA TIBBI MALZEMENAYI VE TICARET AS Total Inventories Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS Total Inventories Chart
MEDITERA TIBBI MALZEMENAYI VE TICARET AS Annual Data
MEDITERA TIBBI MALZEMENAYI VE TICARET AS Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) has a Total Inventories of ₺579 Mil as of Mar. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for MEDITERA TIBBI MALZEMENAYI VE TICARET AS and its competitors.
Is MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Total Inventories too high?
MEDITERA TIBBI MALZEMENAYI VE TICARET AS's current Total Inventories is ₺579 Mil. Overall, MEDITERA TIBBI MALZEMENAYI VE TICARET AS has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Total Inventories compare to ABT and SYK?
MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Total Inventories of ₺579 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Medical Devices & Instruments company?
A good Total Inventories depends on the Medical Devices & Instruments industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for MEDITERA TIBBI MALZEMENAYI VE TICARET AS and its competitors. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's current Total Inventories is ₺579 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MEDITERA TIBBI MALZEMENAYI VE TICARET AS stock overvalued right now?
Based on GuruFocus' analysis, MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) is currently considered Significantly Undervalued. The stock's GF Value™ is ₺43.43, compared to a current price of ₺28.44 — trading 34.5% below its estimated fair value. The current Total Inventories is ₺579 Mil. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR), the current Total Inventories is ₺579 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) Overvalued in 2026?
Based on GuruFocus' analysis, MEDITERA TIBBI MALZEMENAYI VE TICARET AS stock appears to be undervalued.
The current stock price of ₺28.44 is trading 34.5% below its estimated GF Value™ of ₺43.43.
GuruFocus considers MEDITERA TIBBI MALZEMENAYI VE TICARET AS to be Significantly Undervalued.
Key valuation signals for IST:MEDTR:
Total Inventories: ₺579 Mil
GF Value™: ₺43.43 vs. price of ₺28.44 (34.5% below fair value)
No single metric tells the full story. See the IST:MEDTR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS Business Description
MEDITERA TIBBI MALZEME SANAYI VE TICARET AS is engaged in the manufacture of anesthesia and intensive care circuits, the installation, operation, and design of oncology drug preparation and delivery systems, production, sales, and technical service of infusion pumps and sets, and the manufacture of biocidal products.
79GF Score
Get the complete analysis for IST:MEDTR
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:MEDTR has been successfully added to your 
